|
|
|
40
|
2701B
|
DEPO-MEDROL 40MG/ML INJ (PFI/STO) METHYLPREDN
|
METHYLPREDNISOLONE
|
DEPO-MEDROL
|
1ML VIAL
|
C
|
14.79
|
14.79
|
INJECTION
|
0
|
VIAL
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
6804
|
ADRENALS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
2701B
|
DEPO-MEDROL 40MG/ML INJ (PFI) METHYLPRED (C)
|
METHYLPREDNISOLONE
|
DEPO-MEDROL
|
1ML VIAL
|
C
|
14.92
|
14.9236
|
VIAL
|
0
|
VIAL
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
6804
|
ADRENALS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ADRENALS
|
|
|
|
|
42
|
2701B
|
DEPO-MEDROL 40MG/ML INJ (PFI) METHY
|
METHYLPREDNISOLONE
|
DEPO-MEDROL
|
1ML VIAL
|
C
|
14.92
|
14.92
|
VIAL
|
0
|
VIAL
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
6804
|
ADRENALS
|
2026-04-01
|
|
|
IV
|
0
|
ADRENALS
|
|
|
|
|
40
|
2701C
|
METHYLPREDNISOLONE 40MG/ML INJ (MON/PHA)
|
METHYLPREDNISOLONE
|
METHYLPREDNISOLONE
|
2ML VIAL
|
B
|
3.91
|
3.91
|
INJECTION
|
0
|
VIAL
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
6804
|
ADRENALS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
2701C
|
METHYLPREDNISOLONE 40MG/ML INJ (MON (B)
|
METHYLPREDNISOLONE
|
METHYLPREDNISOLONE
|
2ML VIAL
|
B
|
4.29
|
4.29
|
VIAL
|
0
|
VIAL
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
6804
|
ADRENALS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ADRENALS
|
|
|
|
|
42
|
2701D
|
JOHNLEE MPD 40MG/ML INJ (JLP) METHYLPREDNISOLONE
|
METHYLPREDNISOLONE
|
JOHNLEE MPD
|
2ML
|
B
|
3.67
|
3.67
|
VIAL
|
0
|
VIAL
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
6804
|
ADRENALS
|
2026-04-01
|
|
|
IM/SC
|
0
|
ADRENALS
|
|
|
|
|
40
|
3301AW
|
METHYLPREDNISOLONE 0.1% CR (KWA/ATB)
|
METHYLPREDNISOLONE
|
METHYLPREDNISOLONE
|
15G
|
A
|
6.01
|
6.01
|
CREAM
|
2
|
TUBE
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
8406
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
2022-04-01
|
2024-03-31
|
|
TOPICAL
|
0
|
SKIN-MUCOUS MEMBRANE PREPARATIONS
|
|
|
|
|
40
|
3301BE
|
ADVANTAN 0.1% CR (LEO/COL) METHYLPREDNISOLONE
|
METHYLPREDNISOLONE
|
ADVANTAN
|
15G
|
C
|
11.50
|
11.50
|
CREAM
|
0
|
TUBE
|
LEO
|
LEO LABORATORIES LTD.
|
COL
|
COLLINS LTD
|
|
8406
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
2022-04-01
|
2024-03-31
|
|
TOPICAL
|
0
|
SKIN-MUCOUS MEMBRANE PREPARATIONS
|
|
|
|
|
40
|
3302AA
|
METHYLPREDNISOLONE 0.1% OINT (KWA/ATB)
|
METHYLPREDNISOLONE
|
METHYLPREDNISOLONE
|
15G
|
A
|
6.50
|
6.50
|
OINT
|
2
|
TUBE
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
8406
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
2022-04-01
|
2024-03-31
|
|
TOPICAL
|
0
|
SKIN-MUCOUS MEMBRANE PREPARATIONS
|
|
|
|
|
40
|
4121B
|
METHYLPREDNISOLONE SODIUM SUCCINATE 500MG INJ (KWA/ATB)
|
METHYLPREDNISOLONE SODIUM SUCCINATE
|
METHYLPREDNISOLONE SODIUM SUCCINATE
|
500MG VIAL
|
B
|
15.36
|
15.36
|
INJECTION
|
0
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
6804
|
ADRENALS
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
2022-03-30
|
|
|
|
41
|
4121B
|
METHYLPRED. SOD. SUCC. 500MG INJ (KWA) METHYLPREDNISOLONE SO (BQ)
|
METHYLPREDNISOLONE SODIUM SUCCINATE
|
METHYLPRED. SOD. SUCC.
|
500MG VIAL
|
BQ
|
9.7
|
9.7044
|
VIAL
|
0
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
6804
|
ADRENALS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ADRENALS
|
|
|
|
|
40
|
4121D
|
METHYLPREDNISOLONE SODIUM SUCCINATE 500MG INJ (MON/PHA)
|
METHYLPREDNISOLONE SODIUM SUCCINATE
|
METHYLPREDNISOLONE SODIUM SUCCINATE
|
10ML VIAL
|
B
|
10.55
|
10.55
|
INJECTION
|
0
|
VIAL
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
6804
|
ADRENALS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
41
|
4121G
|
METHYLPRED. SOD. SUCC. 500MG INJ (FSB) METHYLPREDNISOLONE SO (BQ)
|
METHYLPREDNISOLONE SODIUM SUCCINATE
|
METHYLPRED. SOD. SUCC.
|
500MG VIAL
|
BQ
|
9.43
|
9.4326
|
VIAL
|
0
|
VIAL
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
6804
|
ADRENALS
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
0
|
ADRENALS
|
|
|
|
|
42
|
4121J
|
METHYLPRED. SOD. SUCC. 50MG/ML INJ (BAX) METHYLPREDNISOLONE
|
METHYLPREDNISOLONE SODIUM SUCCINATE
|
METHYLPRED. SOD. SUCC.
|
10X10ML
|
BQ
|
68.42
|
6.84
|
VIAL
|
0
|
VIAL
|
BAX
|
BAXTER EXPORT CORP.
|
STO
|
BRYDEN STOKES LTD
|
|
6804
|
ADRENALS
|
2026-04-01
|
|
|
IV/IM
|
0
|
ADRENALS
|
|
